Multi-Jurisdictional SDS Authoring: Navigating HazCom 2024, WHMIS 2015, and EU CLP Concentration Disclosure
← Back to Blog Compliance

Multi-Jurisdictional SDS Authoring: Navigating HazCom 2024, WHMIS 2015, and EU CLP Concentration Disclosure

Chemical manufacturers selling US, Canada, and EU face three distinct SDS requirements with staggered deadlines. Manage HazCom 2024, WHMIS, and CLP rules.

by iSi Environmental

If your chemical manufacturing or distribution operation crosses the US-Canada or US-EU border, you are managing not one safety data sheet, but three — each governed by distinct regulatory requirements, conflicting concentration disclosure rules, and staggered compliance deadlines. A single chemical product may require three parallel SDS versions, three sets of hazard classifications, and three separate label strategies. Miss any one of them, and your company faces stacked regulatory exposure across three jurisdictions with penalties ranging from CAD 250,000 to EUR 100,000 to USD 165,514 per violation.

This is not a distant problem. The deadlines are converging: OSHA’s HazCom 2024 manufacturer compliance deadline is May 19, 2026 — 13 days away as of publication. Canada’s WHMIS transition period ended December 14, 2025. The EU’s CLP 21st and 22nd Adaptation to Technical Progress (ATP) amendments are rolling out September 2025 through May 2026. For multinational manufacturers, the time to align parallel SDS strategies is now.

One Chemical, Three Regulatory Frameworks: What Changed

All three jurisdictions claim alignment with the Globally Harmonized System (GHS) Revision 7, but alignment is not equivalence. Each has implemented GHS 7 differently, with distinct concentration disclosure protocols that create compliance friction for manufacturers managing multinational product lines.

OSHA HazCom 2024: The New Prescribed Concentration Range Rule

On May 20, 2024, OSHA finalized an update to the Hazard Communication Standard (29 CFR 1910.1200) introducing what most manufacturers thought was novel: the ability to use prescribed concentration ranges as trade secret protection. The rule takes effect July 19, 2024, with manufacturer compliance required by May 19, 2026.

The innovation: OSHA adopted 13 prescribed concentration ranges that mirror Health Canada’s existing framework. If a manufacturer’s actual chemical concentration is withheld as a trade secret, the SDS must disclose one of these 13 ranges:

  • 0.1–1.0%
  • 0.5–1.5%
  • 1.0–5.0%
  • 3.0–7.0%
  • 5.0–10.0%
  • 7.0–13.0%
  • 10.0–30.0%
  • 15.0–40.0%
  • 30.0–60.0%
  • 45.0–70.0%
  • 60.0–80.0%
  • 65.0–85.0%
  • 80.0–100.0%

For concentrations between 0.1% and 30%, manufacturers may combine two adjacent ranges or select a narrower single range. The intent: narrow enough to give workers a meaningful hazard assessment, wide enough to protect trade secrets.

But here is where multinational complexity begins: Canada adopted this exact framework in 2018 (via amendment to the Hazardous Products Regulation), while the EU allows concentration ranges but imposes no prescribed list. Any range that “allows the hazard assessment” passes under REACH Annex II. A range that works for US and Canadian SDSs may fail under EU scrutiny.

Canada WHMIS 2015: The Deadline You Already Missed

Canada’s Hazardous Products Regulation (HPR) amendment was finalized December 15, 2022, aligning the regulation with GHS Revision 7 (primary) and select Revision 8 elements. The compliance deadline — December 14, 2025 — has already passed. Three-year transition period: finished.

That said, Health Canada announced a compliance promotion approach through November 19, 2027, meaning enforcement is currently focused on voluntary correction rather than aggressive citation. But that tolerance window closes in 18 months. From that date forward, any SDS not meeting amended HPR requirements becomes a violation exposure.

What changed for Canadian manufacturers:

  • SDS Format: The 16-section GHS Annex IV structure (identical to OSHA’s requirement)
  • Three New Hazard Categories: Desensitized explosives, chemicals under pressure, unstable gases (same as OSHA)
  • Concentration Ranges: Identical 13-category list, same trade secret protection philosophy
  • Bilingual Requirement: English + French on all supplier labels and SDS

The critical detail: Canada has been using prescribed concentration ranges since 2018. US manufacturers just adopted them in 2024. This means Canadian manufacturers have a 6-year head start on the operational complexity of managing prescribed ranges.

EU CLP/REACH: Ongoing ATP Implementation with No Single Deadline

The EU’s regulatory framework is decentralized. The CLP Regulation (EC 1272/2008) is amended through Commission Delegated Regulations (ATPs — Adaptations to Technical Progress) that take effect on staggered timelines:

  • 21st ATP (Regulation EU 2024/197): Effective September 1, 2025. Adds 28 new substances to the Annex VI harmonized list, revises 24 existing entries.
  • 22nd ATP (Regulation EU 2024/2564): Effective May 1, 2026. Additional harmonized classifications take effect.

Substances on the market before May 1, 2025 have a grace period until November 1, 2026 to comply with new requirements. After that date, no legacy labeling or SDS formats are acceptable.

The critical difference: EU law has no prescribed concentration ranges. Instead, manufacturers must disclose ingredient concentrations or concentration ranges that “allow hazard assessment” by the reader. This is deliberately vague, shifting the compliance burden to the manufacturer to justify their chosen range as sufficient. An overly broad range risks enforcement action. Too narrow, and competitors learn your exact formulation.

For multinational manufacturers, this creates a dilemma: if you use a prescribed range from the US/Canada list (e.g., 10.0–30.0%), is that range “sufficient for hazard assessment” under EU standards? Guidance is sparse. Most manufacturers choose narrower EU-specific ranges to avoid enforcement risk, but that means maintaining separate range-selection criteria by jurisdiction.

The Compliance Timeline Collision: May 2026 is Only the Beginning

Deadlines are overlapping and staggered in ways that create operational bottlenecks.

Now – September 2025 (EU 21st ATP): New CLP hazard entries take effect. If your products contain any listed substances, reclassification is required immediately.

September 2025 – May 1, 2026 (EU 22nd ATP): 22nd ATP entries take effect. Second wave of reclassification and SDS updates.

May 19, 2026 (OSHA HazCom 2024 Deadline): US manufacturers must complete all SDS updates and label redesigns. This is the most aggressive deadline and affects the broadest set of manufacturers.

May 1, 2026 – November 1, 2026 (EU Grace Period End): Substances placed on the market before May 1, 2025 must complete EU compliance. Any non-compliant SDS in circulation after November 1 is a violation.

November 20, 2026 (OSHA Secondary Deadline): US distributors must provide updated SDS to customers.

November 19, 2027 (Canada/OSHA Employer Deadline): Health Canada compliance promotion period ends. Employers must complete worker training on new hazard classifications.

For a multinational manufacturer with products in all three markets, the realistic compliance window looks like this: September 2025 through May 2026 is the critical period. You have 8 months to complete SDS revisions across three jurisdictions with three different technical requirements and three different concentration disclosure strategies. Miss any one, and you have stacked violation exposure starting May 19, 2026 (US) and November 1, 2026 (EU).

Prescribed Concentration Ranges: Why One Size Does Not Fit All

The prescribed concentration range frameworks in the US and Canada appear identical — 13 categories, same values — but their application differs in subtle but significant ways.

US and Canada: Prescribed Ranges as Trade Secret Gateway

Both OSHA and Health Canada allow prescribed ranges only when the actual concentration is withheld as a trade secret. This is critical: if you disclose the actual concentration, you cannot use a prescribed range. Conversely, if you use a prescribed range, downstream users (employers, distributors) understand that your exact concentration is confidential.

The practical intent: narrow enough ranges to allow hazard assessment, wide enough to protect formulation secrets.

For US manufacturers, this is new (since July 2024). For Canadian manufacturers, this has been standard since 2018. Canadian manufacturers have already worked through the operational complexity: managing prescribed ranges in centralized SDS repositories, explaining the ranges to distributors and regulatory auditors, and defending range selections if challenged.

EU: Discretionary Ranges with a Hazard Assessment Threshold

The EU allows concentration ranges but imposes no prescribed list. Instead, REACH Annex II requires that “the concentration range must allow hazard assessment.” This is deliberately vague. The ECHA guidance document (the official interpretation) provides no examples of acceptable vs. unacceptable ranges.

The result: manufacturers must make a defensible judgment call. A range of 10.0–30.0% may be acceptable for a substance with a hazard threshold of 1%, but unacceptable for a sensitizer with a threshold of 0.1%. Enforcement is at the Member State level, meaning tolerances vary by country (Germany enforces strictly; some other Member States are more permissive).

For US and Canadian manufacturers with EU operations, this creates an operational problem: you cannot simply copy your OSHA/WHMIS prescribed range onto the EU SDS. You must review the specific substance, its hazard thresholds, and the regulatory landscape in the specific Member State where the product is sold, then select a range you can defend.

Trade Secret Protection: The Confidentiality vs. Transparency Spectrum

All three regimes allow some form of ingredient confidentiality protection, but the scope and conditions differ significantly.

US (OSHA HazCom 2024): The ingredient identity can be withheld if you use a prescribed concentration range. The range becomes the substitute for specificity. Trade secret status is established by claiming it; no notification to OSHA required.

Canada (WHMIS 2015): Similar to OSHA. Ingredient identity withheld if prescribed range is provided. Health Canada does not require pre-notification of trade secret claims.

EU (REACH Annex II): Ingredient identity can be withheld under narrow conditions, but the rationale must be documented and defensible. Identity withholding is typically granted only for actual chemical names that reveal proprietary synthesis routes or formulation secrets — not for generic descriptors. Concentration withholding (replaced by range) is more readily accepted.

The EU distinction matters: you cannot claim trade secret protection for a “proprietary surfactant blend” if ECHA can identify the likely ingredients from market knowledge. EU guidance expects manufacturers to withhold only information that is genuinely unique to their formulation.

For multinational manufacturers, this creates asymmetry: a formulation protecting trade secrets in the US (via prescribed range on the SDS) may not pass EU scrutiny because the EU’s bar for confidentiality is higher. Your US SDS and EU SDS may look similar but carry different levels of disclosed information.

Penalty Exposure Across Three Jurisdictions

Compliance gaps stack across jurisdictions, and penalties escalate quickly.

United States (OSHA)

OSHA cites HazCom violations at $16,550 per serious violation (2025 adjusted rate) and up to $165,514 for willful or repeat violations. Citations stack per product. A facility with 30 products requiring SDS updates faces a potential $496,500 exposure at the serious violation rate.

However, if you take corrective action upon discovering a violation (even before OSHA inspection), you qualify for a 15% penalty reduction (effective July 2025). This creates an incentive for self-auditing.

Canada (Health Canada)

Canada’s penalty structure is steeper at the upper end:

  • Summary Conviction: CAD 250,000 (first offense), CAD 500,000 (subsequent)
  • On Indictment: Up to CAD 5,000,000 + 2 years imprisonment

However, Health Canada has announced a compliance promotion approach through November 2027, meaning prosecution is unlikely for good-faith non-compliance. Once that period ends, enforcement posture may shift.

Additionally, officers, directors, and agents who authorize or acquiesce to non-compliance can be held personally liable. This creates personal accountability that US law does not impose as directly.

European Union (Decentralized by Member State)

Enforcement is the responsibility of each Member State, and penalty ranges vary:

CountryTypical Penalty Range
GermanyEUR 10,000–EUR 300,000 per violation
FranceEUR 5,000–EUR 75,000 per serious violation
NetherlandsEUR 2,500–EUR 100,000 per breach
UK (Post-Brexit)GBP 5,000–GBP 80,000 per breach

Germany’s enforcement is known to be aggressive; France and the Netherlands are moderate. The EU has no unified penalty structure, making cross-border risk assessment difficult. A violation in Germany is far costlier than in another Member State.

Your Compliance Checklist: What to Do Now (May 2026 Timeline)

For multinational manufacturers, the practical pathway is:

Immediate (June–July 2026):

  1. Audit your chemical inventory across all three jurisdictions. Identify which products are sold in US, Canada, and/or EU. Flag any products containing substances listed in EU CLP 21st or 22nd ATP (Annex VI).

  2. Complete US HazCom 2024 SDS updates. Deadline is May 19, 2026 (effectively now for post-publication efforts). Ensure:

    • 16-section GHS Annex IV format
    • Three new hazard categories reviewed and applied if applicable
    • Prescribed concentration ranges selected (if withholding actual concentration as trade secret)
    • Container labels redesigned with GHS pictograms and signal words

  3. Validate Canada WHMIS compliance. Even though the December 2025 deadline has passed, audit current SDS against amended HPR requirements:

    • 16-section format
    • Same three new hazard categories
    • Prescribed ranges (if applicable)
    • Bilingual labels (English/French)

  4. Begin EU CLP updates. Check if any products are affected by 21st ATP entries (effective September 1, 2025, but retroactive application expected). Plan for 22nd ATP (May 1, 2026) impact.

Intermediate (August–December 2026):

  1. Implement EU SDS revisions. Select concentration ranges defensible under REACH Annex II (narrower than US/Canada prescribed ranges if necessary). Document the rationale for any confidentiality claims.

  2. Distribute updated SDS to downstream customers. US distributors have until November 20, 2026 to provide updated materials. Canadian and EU distributors should do so immediately to avoid supply chain delays.

  3. Prepare for employer/worker training. US employers must retrain workers by November 19, 2027 on new hazard classifications. Provide them training resources aligned with your updated SDS.

Ongoing (2027+):

  1. Monitor regulatory updates. OSHA, Health Canada, and ECHA continue to issue guidance and amendments. Subscribe to regulatory alerts for your operating jurisdictions.

  2. Track Member State enforcement trends in your EU markets. If you sell primarily in Germany, monitor German enforcement authority (BG BAU, Gewerbeaufsicht) activity. Adjust risk posture accordingly.

How iSi Environmental Supports Multi-Jurisdictional SDS Compliance

Managing parallel SDS authoring across three jurisdictions requires expertise in each framework and the discipline to maintain consistency while accommodating jurisdiction-specific requirements. Many manufacturers discover during this process that their SDS repositories contain legacy documents, inconsistent hazard classifications, and incomplete ingredient disclosures — all of which create rework during the compliance sprint.

iSi Environmental helps chemical manufacturers and distributors audit existing SDS libraries, reconcile hazard classifications across OSHA, Health Canada, and ECHA standards, select defensible concentration ranges and trade secret strategies for each jurisdiction, and implement jurisdiction-specific label and SDS updates within the May 2026–November 2026 window.

For multinational manufacturers operating on compressed timelines, iSi’s multi-jurisdictional compliance approach reduces the risk of stacked violations and ensures that formulation secrets are protected appropriately under each regulatory regime while worker hazard information remains transparent and legally sufficient.

Sources

Tags: